Biogen is a world-leading biotechnology company focused on discovering, developing, and delivering innovative therapies for serious diseases. Its commitment to neurological and neurodegenerative diseases, such as multiple sclerosis, Alzheimer's disease, and Parkinson's disease, has led to the development of groundbreaking treatments that improve the lives of millions of people worldwide. Biogen's dedication to advancing medical science and improving patient outcomes makes it a trailblazer in the biotechnology industry.
